{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:51:23Z","timestamp":1792047083940,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.gtc.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T11:21:34Z","timestamp":1757503294000},"page":"805-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and Management of Small Intestinal Bacterial Overgrowth in Pediatric Short Bowel Syndrome"],"prefix":"10.1016","volume":"54","author":[{"given":"Nikhil","family":"Pai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina N.","family":"Sainath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: small intestinal bacterial overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2025.07.005_bib2","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/jpen.1809","article-title":"Factors related to the development of small-bowel bacterial overgrowth in pediatric intestinal failure: a retrospective cohort study","volume":"44","author":"Belza","year":"2020","journal-title":"J Parenter Enteral Nutr"},{"issue":"3","key":"10.1016\/j.gtc.2025.07.005_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.gtc.2020.04.010","article-title":"Small intestinal bacterial overgrowth","volume":"49","author":"Ginnebaugh","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"issue":"6","key":"10.1016\/j.gtc.2025.07.005_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jpedsurg.2012.03.019","article-title":"Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review","volume":"47","author":"Gutierrez","year":"2012","journal-title":"J Pediatr Surg"},{"issue":"6","key":"10.1016\/j.gtc.2025.07.005_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jpeds.2009.12.008","article-title":"The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses","volume":"156","author":"Cole","year":"2010","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00535-017-1371-9","article-title":"Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth","volume":"53","author":"Su","year":"2018","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2025.07.005_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.mpg.0000228116.52229.7b","article-title":"Serial transverse enteroplasty for management of refractory d-lactic acidosis in short-bowel syndrome","volume":"43","author":"Modi","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"10.1016\/j.gtc.2025.07.005_bib8","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s10620-017-4726-4","article-title":"A prospective evaluation of ileocecal valve dysfunction and intestinal motility derangements in small intestinal bacterial overgrowth","volume":"62","author":"Chander","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.gtc.2025.07.005_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jamcollsurg.2018.07.657","article-title":"Remnant small bowel length in pediatric short bowel syndrome and the correlation with intestinal dysbiosis and linear growth","volume":"227","author":"Engelstad","year":"2018","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1940792","article-title":"Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections","volume":"13","author":"Th\u00e4nert","year":"2021","journal-title":"Gut Microbes"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2025.07.005_bib11","first-page":"ofae631","article-title":"Small intestinal bacterial overgrowth and bloodstream infection in the pediatric intestinal failure population","volume":"12","author":"Barclay","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.gtc.2025.07.005_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/j.gastro.2022.04.002","article-title":"Small intestinal bacterial overgrowth\u2014pathophysiology and its implications for definition and management","volume":"163","author":"Bushyhead","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2025.07.005_bib13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/0115426505020006634","article-title":"D-Lactic acidosis","volume":"20","author":"Petersen","year":"2005","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2083417","article-title":"Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease","volume":"14","author":"Kastl","year":"2022","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.gtc.2025.07.005_bib15","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000078","article-title":"Small intestinal bacterial overgrowth","volume":"10","author":"Rao","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/antibiotics12020263","article-title":"Diagnosis by microbial culture, breath tests and urinary excretion tests, and treatments of small intestinal bacterial overgrowth","volume":"12","author":"Maeda","year":"2023","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.gtc.2025.07.005_bib18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0016-5085(99)70336-7","article-title":"Antibiotic efficacy in small intestinal bacterial overgrowth\u2013related chronic diarrhea: a crossover, randomized trial","volume":"117","author":"Attar","year":"1999","journal-title":"Gastroenterology"},{"issue":"11\u201312","key":"10.1016\/j.gtc.2025.07.005_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1365-2036.2003.01800.x","article-title":"Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn\u2019s disease","volume":"18","author":"Castiglione","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/anae.1995.1002","article-title":"Reduction of metronidazole by hydrogenase from clostridia","volume":"1","author":"Church","year":"1995","journal-title":"Anaerobe"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2036.2000.00751.x","article-title":"Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth","volume":"14","author":"Di Stefano","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.gtc.2025.07.005_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1365-2036.2005.02397.x","article-title":"Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome","volume":"21","author":"Di Stefano","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e3180536784","article-title":"Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth","volume":"333","author":"Majewski","year":"2007","journal-title":"Am J Med Sci"},{"issue":"7","key":"10.1016\/j.gtc.2025.07.005_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2036.2007.03259.x","article-title":"High dosage rifaximin for the treatment of small intestinal bacterial overgrowth","volume":"25","author":"Scarpellini","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10620-007-9839-8","article-title":"Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS","volume":"53","author":"Yang","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2005.02516.x","article-title":"Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth","volume":"22","author":"Lauritano","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib27","first-page":"51","article-title":"Pharmacokinetic study of rifaximin after oral administration in healthy volunteers","volume":"14","author":"Descombe","year":"1994","journal-title":"Int J Clin Pharmacol Res"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.gtc.2025.07.005_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/apt.12479","article-title":"Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth","volume":"38","author":"Shah","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.gtc.2025.07.005_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MCG.0b013e3181c64c90","article-title":"A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test","volume":"44","author":"Low","year":"2010","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2025.07.005_bib31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPG.0b013e3181a0d269","article-title":"Use and safety of rifaximin in children with inflammatory bowel disease","volume":"49","author":"Muniyappa","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib32","article-title":"Small intestinal bacterial overgrowth in children: clinical features and treatment response","volume":"3","author":"Peinado","year":"2022","journal-title":"JPGN Rep"},{"issue":"168","key":"10.1016\/j.gtc.2025.07.005_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/adc.33.168.165","article-title":"Recurrent abdominal pains: a field survey of 1,000 school children","volume":"33","author":"Apley","year":"1958","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.gtc.2025.07.005_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MPG.0b013e3181effa3b","article-title":"Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain","volume":"52","author":"Collins","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.gtc.2025.07.005_bib35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/children12030351","article-title":"Small intestinal bacterial overgrowth in children with short bowel syndrome: risk factors, clinical presentation and management\u2014a single-center experience","volume":"12","author":"Velimirovic","year":"2025","journal-title":"Children"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib36","first-page":"111","article-title":"Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole","volume":"13","author":"Lauritano","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8322","key":"10.1016\/j.gtc.2025.07.005_bib37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(83)91442-3","article-title":"Metronidazole in prevention of cholestasis associated with total parenteral nutrition","volume":"321","author":"Capron","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-018-9147-6","article-title":"Metronidazole-induced encephalopathy: a systematic review","volume":"267","author":"S\u00f8rensen","year":"2020","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib39","first-page":"192","article-title":"Metronidazole induced neuropathy","volume":"48","author":"Gupta","year":"2000","journal-title":"Neurol India"},{"issue":"3","key":"10.1016\/j.gtc.2025.07.005_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/jb.94.3.789-790.1967","article-title":"Biological activity of the antibiotic components of the gentamicin complex","volume":"94","author":"Weinstein","year":"1967","journal-title":"J Bacteriol"},{"key":"10.1016\/j.gtc.2025.07.005_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1651-2227.1992.tb12390.x","article-title":"Oral gentamicin is not effective treatment for persistent diarrhea","volume":"81","author":"Bartlett","year":"1992","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3748\/wjg.14.313","article-title":"Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats","volume":"14","author":"Wu","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1572-0241.1999.01016.x","article-title":"Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome","volume":"94","author":"Bouhnik","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.gtc.2025.07.005_bib44","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.3748\/wjg.v22.i11.3078","article-title":"Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections","volume":"22","author":"McFarland","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2025.07.005_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5114\/pg.2018.74228","article-title":"Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection","volume":"13","author":"Konrad","year":"2018","journal-title":"Gastroenterol Rev"},{"issue":"3","key":"10.1016\/j.gtc.2025.07.005_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MPG.0b013e3182952e93","article-title":"Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum","volume":"57","author":"Tahan","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.gtc.2025.07.005_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543780902780175","article-title":"Review of rifaximin as treatment for SIBO and IBS","volume":"18","author":"Pimentel","year":"2009","journal-title":"Expet Opin Invest Drugs"},{"issue":"12","key":"10.1016\/j.gtc.2025.07.005_bib48","article-title":"Chronic intestinal pseudo-obstruction: progress in management?","volume":"29","author":"Di","year":"2017","journal-title":"Neuro Gastroenterol Motil"},{"issue":"21","key":"10.1016\/j.gtc.2025.07.005_bib49","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM199111213252102","article-title":"Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma","volume":"325","author":"Soudah","year":"1991","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.gtc.2025.07.005_bib50","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1572-0241.2008.02030.x","article-title":"Small intestinal bacterial overgrowth recurrence after antibiotic therapy","volume":"103","author":"Lauritano","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1155\/2011\/604643","article-title":"Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure","volume":"25","author":"Malik","year":"2011","journal-title":"Can J Gastroenterol"},{"issue":"12","key":"10.1016\/j.gtc.2025.07.005_bib52","doi-asserted-by":"crossref","DOI":"10.29011\/2575-9760.000182","article-title":"Cycled enteral antibiotics in suspected small bowel bacterial overgrowth complicating short bowel syndrome - experience from a tertiary neonatal centre of Canada","volume":"5","author":"Sur","year":"2017","journal-title":"J Surg"},{"key":"10.1016\/j.gtc.2025.07.005_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/476215","article-title":"D-lactic acidosis: an underrecognized complication of short bowel syndrome","volume":"2015","author":"Kowlgi","year":"2015","journal-title":"Gastroenterol Res Pract"},{"issue":"7","key":"10.1016\/j.gtc.2025.07.005_bib54","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/nu16071083","article-title":"Do herbal supplements and probiotics complement antibiotics and diet in the management of SIBO? a randomized clinical trial","volume":"16","author":"Redondo-Cuevas","year":"2024","journal-title":"Nutrients"},{"issue":"13","key":"10.1016\/j.gtc.2025.07.005_bib55","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.3390\/ijms25137341","article-title":"Identification of SIBO Subtypes along with nutritional status and diet as key elements of SIBO therapy","volume":"25","author":"Wielgosz-Grochowska","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/acm.2020.0275","article-title":"Alternative treatment approaches to small intestinal bacterial overgrowth: a systematic review","volume":"27","author":"Nickles","year":"2021","journal-title":"J Alternative Compl Med"},{"key":"10.1016\/j.gtc.2025.07.005_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n1554","article-title":"Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study","author":"Narula","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/B:DDAS.0000011605.43979.e1","article-title":"A 14-day elemental diet is highly effective in normalizing the lactulose breath test","volume":"49","author":"Pimentel","year":"2004","journal-title":"Dig Dis Sci"},{"issue":"16","key":"10.1016\/j.gtc.2025.07.005_bib59","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.3390\/nu14163382","article-title":"Efficacy of an irritable bowel syndrome diet in the treatment of small intestinal bacterial overgrowth: a narrative review","volume":"14","author":"Wielgosz-Grochowska","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09964-7","article-title":"Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders","volume":"10","author":"Saffouri","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/15748847113089990048","article-title":"Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation","volume":"8","author":"Rosania","year":"2013","journal-title":"Curr Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib62","first-page":"604","article-title":"Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)--a pilot study","volume":"140","author":"Khalighi","year":"2014","journal-title":"Indian J Med Res"},{"issue":"4","key":"10.1016\/j.gtc.2025.07.005_bib63","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth","volume":"51","author":"Zhong","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2025.07.005_bib64","first-page":"323","article-title":"[Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study]","volume":"40","author":"Soifer","year":"2010","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib65","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/ajg.2009.91","article-title":"Bacillus clausii as a treatment of small intestinal bacterial overgrowth","volume":"104","author":"Gabrielli","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib66","first-page":"89","article-title":"Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin","volume":"52","author":"Cuoco","year":"2006","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.gtc.2025.07.005_bib67","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000005953","article-title":"Probiotic-associated central venous catheter bloodstream infections lead to increased mortality in the ICU","author":"Mayer","year":"2023","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s40168-023-01690-z","article-title":"Anti-diarrheal drug loperamide induces dysbiosis in zebrafish microbiota via bacterial inhibition","volume":"11","author":"Stevick","year":"2023","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis","volume":"11","author":"Lo","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cgh.2023.06.001","article-title":"Defining small intestinal bacterial overgrowth by culture and high throughput sequencing","volume":"22","author":"Leite","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib71","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jpeds.2015.01.004","article-title":"Small bowel bacterial overgrowth associated with persistence of abdominal symptoms in children treated with a proton pump inhibitor","volume":"166","author":"Sieczkowska","year":"2015","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.gtc.2025.07.005_bib72","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapediatrics.2014.696","article-title":"Changes in gastric and lung microflora with acid suppression","volume":"168","author":"Rosen","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12876-021-01630-x","article-title":"Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2025.07.005_bib74","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1177\/0148607115619931","article-title":"Fecal transplantation successfully treats recurrent d-lactic acidosis in a child with short bowel syndrome","volume":"41","author":"Davidovics","year":"2017","journal-title":"J Parenter Enteral Nutr"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib75","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-017-4864-8","article-title":"Small intestinal bacterial overgrowth: should screening be included in the pre-fecal microbiota transplantation evaluation?","volume":"63","author":"Allegretti","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.gtc.2025.07.005_bib76","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MPG.0000000000002043","article-title":"Intestinal microbial and metabolic alterations following successful fecal microbiota transplant for d-lactic acidosis","volume":"67","author":"Bulik-Sullivan","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2025.07.005_bib77","unstructured":"Pai N, Chowdhury F, Lilman V, et al., Pilot feasibility study of fecal microbiota transplant for the treatment of small intestinal bacterial overgrowth, ClinicalTrials.gov, 2025."},{"key":"10.1016\/j.gtc.2025.07.005_bib78","unstructured":"National Institutes of Health. ClinicalTrials.gov, National Center for Biotechnology Information, 2025."},{"issue":"7332","key":"10.1016\/j.gtc.2025.07.005_bib79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib80","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1053\/j.gastro.2011.04.062","article-title":"Engineering of a multicellular organotypic model of the human intestinal mucosa","volume":"141","author":"Salerno-Goncalves","year":"2011","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2025.07.005_bib81","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1462-5822.2004.00594.x","article-title":"A three-dimensional tissue culture model for the study of attach and efface lesion formation by enteropathogenic and enterohaemorrhagic Escherichia coli","volume":"7","author":"Carvalho","year":"2005","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.gtc.2025.07.005_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k2179","article-title":"Role of the gut microbiota in nutrition and health","author":"Valdes","year":"2018","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.gtc.2025.07.005_bib83","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gtc.2025.07.005_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02032-23","article-title":"Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases","volume":"15","author":"Zeng","year":"2024","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.gtc.2025.07.005_bib85","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2468-1253(24)00311-X","article-title":"International consensus statement on microbiome testing in clinical practice","volume":"10","author":"Porcari","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855325000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855325000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T15:48:47Z","timestamp":1765986527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855325000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0889855325000500"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2025.07.005","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Small Intestinal Bacterial Overgrowth in Pediatric Short Bowel Syndrome","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}